Cargando…
Validation of the NeuMoDx™ SARS-CoV-2 assay with COPAN eNAT® and E&O Viral PCR Sample Solution collection media types in comparison with other validated SARS-CoV-2 RNA assays
OBJECTIVES: This study aimed to confirm NeuMoDx™ SARS-CoV-2 assay (NeuMoDx assay) functionality using off-label collection media, determine assay performance versus other SARS-CoV-2 RNA assays, and assess any cross-reactivity with other respiratory viruses (human coronavirus NL63, influenza, and res...
Autores principales: | Baird, Daniel, Muir, Alana, Logan, Lisa, MacLennan, Mairiead |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287588/ https://www.ncbi.nlm.nih.gov/pubmed/35850427 http://dx.doi.org/10.1016/j.ijid.2022.07.024 |
Ejemplares similares
-
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test
por: Mostafa, Heba H., et al.
Publicado: (2020) -
Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay
por: Meletis, Georgios, et al.
Publicado: (2022) -
Validation of a modified CDC assay and performance comparison with the NeuMoDx™ and DiaSorin® automated assays for rapid detection of SARS-CoV-2 in respiratory specimens
por: Lima, Amorce, et al.
Publicado: (2020) -
Copan eNAT Transport System To Address Challenges in COVID-19 Diagnostics in Regions with Limited Testing Access
por: Richard-Greenblatt, Melissa, et al.
Publicado: (2021) -
Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays
por: Quinton, Mikayla, et al.
Publicado: (2022)